What did CM Life Sciences pay for Sema4?

CM Life Sciences acquired Sema4 for $2.07B in 2021, equivalent to 10.90x revenue. Target revenue was approximately $190.0M.

Sema4 is a healthcare it business.

What multiple did CM Life Sciences pay for Sema4?

10.90x revenue, based on disclosed deal value of $2.07B and disclosed financials.

M&A TRANSACTION · 2021

Sema4 acquired by CM Life Sciences

$2.07B· 10.90x revenue

Target

Sema4

Acquirer

CM Life Sciences

Disclosed financials at time of acquisition

Revenue

$190.0M

EBITDA

—

Deal Value

$2.07B

EV/EBITDA

—

Context

This $2.07B acquisition of Sema4 by CM Life Sciences sits in the healthcare it sub-vertical.

Source

Data sourced from SEC filings and investor presentations. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Sema4 acquisition.

Citation: ExitValue.ai. (2021). Sema4 acquired by CM Life Sciences. https://exitvalue.ai/deals/sema4-acquired-by-cm-life-sciences-hc-2021-0107